Tell Us What You Think

Rate your Quintiles.com experience

Subscribe to Email Based on Your Interests

Set preferences

Information Library

Enrollment & retention - Phase IIIB/IV

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by: Most Recent
  • Title
  • Diabetes Outcomes

    September 8, 2009
    This Phase IIIB diabetes study involved cardiovascular outcomes assessed over 6 years. Learn how Quintiles helped the customer overcome the challenges of patient retention, data collection and evaluation.

  • Post-Marketing Commitment Study

    June 30, 2009
    Quintiles developed creative and effective solutions to deliver quality data, cost efficiently and ahead of schedule.

  • Antibiotic Safety Assessment

    March 25, 2009
    A major pharmaceutical company presented Quintiles with a pressing challenge – to collect extensive amounts of Phase IV data in compressed time windows because the treatment conditions were subject to seasonal variants.